s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Friday, June 4, 2021
Accession number
0001140361-21-019839
Documents
424B3
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header